GeoVax Labs Change in Accounts Receivable 2010-2025 | GOVX

GeoVax Labs change in accounts receivable from 2010 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.

GeoVax Labs Change in Accounts Receivable 2010-2025 | GOVX

GeoVax Labs change in accounts receivable from 2010 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$231B
Amgen (AMGN)$161.4B
Gilead Sciences (GILD)$139.9B
Vertex Pharmaceuticals (VRTX)$96.3B
Bristol Myers Squibb (BMY)$93.3B
CSL (CSLLY)$83.8B
GSK (GSK)$76.1B
Regeneron Pharmaceuticals (REGN)$61.5B
Alnylam Pharmaceuticals (ALNY)$54.9B
Argenex SE (ARGX)$41.3B
BioNTech SE (BNTX)$26.7B
Royalty Pharma (RPRX)$21.3B
Insmed (INSM)$21.2B
Biogen (BIIB)$19.5B
Incyte (INCY)$15.2B
Illumina (ILMN)$15B
Genmab (GNMSF)$14.7B
Genmab (GMAB)$14.2B
BioMarin Pharmaceutical (BMRN)$11.9B
Ascendis Pharma (ASND)$11.4B
QIAGEN (QGEN)$11.1B
Moderna (MRNA)$10.7B
Swedish Orphan Biovitrum (BIOVF)$10.6B
Exelixis (EXEL)$10.1B
Verona Pharma American Depositary Share (VRNA)$9B
Exact Sciences (EXAS)$8.9B
Bio-Techne Corp (TECH)$8.6B
Blueprint Medicines (BPMC)$8.3B
Roivant Sciences (ROIV)$7.9B
Halozyme Therapeutics (HALO)$7.5B